Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-11-23 18:25:28 UTC |
---|
Updated at | 2021-08-19 23:59:13 UTC |
---|
NP-MRD ID | NP0002622 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Ethacrynic acid |
---|
Provided By | BMRB |
---|
Description | Ethacrynic acid, also known as ethacrynate or edecrina, belongs to the class of organic compounds known as chlorophenoxyacetates. Chlorophenoxyacetates are compounds containing a phenoxyacetate that carries one or more chlorine atoms on the benzene ring. Ethacrynic acid is a drug which is used for the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure. In humans, ethacrynic acid is involved in the ethacrynic acid action pathway. Ethacrynic acid is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Ethacrynic acid was first documented in 1994 (PMID: 7932170). Based on a literature review very few articles have been published on Ethacrynic acid (PMID: 34286113) (PMID: 34239398) (PMID: 34156246). |
---|
Structure | CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1 InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17) |
---|
Synonyms | Value | Source |
---|
(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid | ChEBI | Acide etacrynique | ChEBI | Acido etacrinico | ChEBI | Acidum etacrynicum | ChEBI | Crinuryl | ChEBI | Edecril | ChEBI | Edecrina | ChEBI | Endecril | ChEBI | Etacrinic acid | ChEBI | Ethacrynate | ChEBI | Hidromedin | ChEBI | Hydromedin | ChEBI | Methylenebutyrylphenoxyacetic acid | ChEBI | Mingit | ChEBI | Otacril | ChEBI | Reomax | ChEBI | Taladren | ChEBI | Uregit | ChEBI | Etacrynic acid | Kegg | (2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetate | Generator | Etacrinate | Generator | Methylenebutyrylphenoxyacetate | Generator | Etacrynate | Generator | Etakrinic acid | HMDB | Ethacryinic acid | HMDB | Acid, ethacrinic | HMDB | Ethacrinic acid | HMDB | Ethacrynate sodium | HMDB | Ethacrynic acid, sodium salt | HMDB | Sodium, ethacrynate | HMDB | Acid, etacrynic | HMDB | Acid, ethacrynic | HMDB | Edecrin | HMDB |
|
---|
Chemical Formula | C13H12Cl2O4 |
---|
Average Mass | 303.1380 Da |
---|
Monoisotopic Mass | 302.01126 Da |
---|
IUPAC Name | 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid |
---|
Traditional Name | ethacrynic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1 |
---|
InChI Identifier | InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17) |
---|
InChI Key | AVOLMBLBETYQHX-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as chlorophenoxyacetates. Chlorophenoxyacetates are compounds containing a phenoxyacetate that carries one or more chlorine atoms on the benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenoxyacetic acid derivatives |
---|
Direct Parent | Chlorophenoxyacetates |
---|
Alternative Parents | Not Available |
---|
Substituents | Not Available |
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Lacreta FP, Brennan JM, Nash SL, Comis RL, Tew KD, O'Dwyer PJ: Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer. J Pharmacol Exp Ther. 1994 Sep;270(3):1186-91. [PubMed:7932170 ]
- Ismail A, Sawmi J, Mannervik B: Marmoset glutathione transferases with ketosteroid isomerase activity. Biochem Biophys Rep. 2021 Jul 12;27:101078. doi: 10.1016/j.bbrep.2021.101078. eCollection 2021 Sep. [PubMed:34286113 ]
- Moffett BS, Kulik K, Khichi M, Arikan A: Acetazolamide-Associated Acute Kidney Injury in Critically Ill Pediatric Patients. J Pediatr Pharmacol Ther. 2021;26(5):467-471. doi: 10.5863/1551-6776-26.5.467. Epub 2021 Jun 28. [PubMed:34239398 ]
- Biancalana L, Kostrhunova H, Batchelor LK, Hadiji M, Degano I, Pampaloni G, Zacchini S, Dyson PJ, Brabec V, Marchetti F: Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity. Inorg Chem. 2021 Jul 5;60(13):9529-9541. doi: 10.1021/acs.inorgchem.1c00641. Epub 2021 Jun 22. [PubMed:34156246 ]
|
---|